Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4067419 | 0.84 | NLRP3 (0.36) | NLRP3 | |
| SCHEMBL4067956 | 0.84 | NLRP3 (0.38) | NLRP3CYP3A4CYP2C19 | |
| SCHEMBL9964233 | 0.79 | PTPN1 (0.32) | NLRP3CYP3A4CYP2C19 | |
| SCHEMBL4072145 | 0.77 | PTPN1 (0.33) | NLRP3CYP3A4CYP2C19 | |
| SCHEMBL4075692 | 0.75 | NLRP3 (0.36) | NLRP3CYP3A4CYP2C19 | |
| SCHEMBL4075689 | 0.70 | PTPN1 (0.35) | NLRP3CYP3A4CYP2C19 | |
| SCHEMBL11236136 | 0.65 | APOBEC3A (0.61) | NLRP3CYP3A4CYP2C19 | |
| SCHEMBL17192658 | 0.62 | — | — | |
| SCHEMBL12335189 | 0.62 | — | — | |
| SCHEMBL22812991 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2365050-B1 | DI-AMIDO GELLANT FOR USE IN CONSUMER PRODUCT COMPOSITIONS | PROCTER & GAMBLE (US) | 2016-08-10 | — | — | EP | disclosed |
| US-8309507-B2 | Processes for making fluid detergent compositions comprising a di-amido gellant | THE PROCTER & GAMBLE COMPANY (US) | 2012-11-13 | — | — | US | disclosed |
| US-8207107-B2 | Di-amido gellant for use in consumer product compositions | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-26 | — | — | US | disclosed |
| US-20120151881-A1 | PROCESSES FOR MAKING FLUID DETERGENT COMPOSITIONS COMPRISING A DI-AMIDO GELLANT | FERNANDEZ PRIETO SUSANA (ES) | 2012-06-21 | — | — | US | disclosed |
| US-20110224455-A1 | Di-Amido Gellant For Use In Consumer Product Compositions | THE PROCTER & GAMBLE COMPANY | 2011-09-15 | — | — | US | disclosed |
| EP-2365051-A1 | Fluid detergent compositions comprising a di-amido gellant, and process for making | The Procter & Gamble Company (US) | 2011-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224455-A1 | Di-Amido Gellant For Use In Consumer Product Compositions | DAGLA, GNPAT, CDIPT | NLRP3 2036/4885CYP3A4 1815/4885CYP2C19 319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.